Browse Category

Analyst Ratings News 14 December 2025 - 15 December 2025

Linde Stock (LIN) Rallies as Citi Names It a New Top Pick: Today’s News, Analyst Forecasts, and What to Watch Next (Dec. 15, 2025)

Linde Stock (LIN) Rallies as Citi Names It a New Top Pick: Today’s News, Analyst Forecasts, and What to Watch Next (Dec. 15, 2025)

Dec. 15, 2025 — Linde plc (NASDAQ: LIN), the world’s largest industrial gases company, is back in the spotlight after a sharp move higher tied to fresh Wall Street commentary and renewed debate over whether the stock’s recent pullback has gone too far. In the latest trading update available on Monday, Linde shares were last seen around $418.75, up about…
Coinbase (COIN) Stock Slides on Dec. 15, 2025: Analyst Price-Target Cuts, Prediction Markets Buzz, and the Big Catalysts Investors Are Watching

Coinbase (COIN) Stock Slides on Dec. 15, 2025: Analyst Price-Target Cuts, Prediction Markets Buzz, and the Big Catalysts Investors Are Watching

Coinbase Global, Inc. (NASDAQ: COIN) is starting the week under pressure as crypto markets wobble and Wall Street refocuses on a near-term catalyst: Coinbase’s “System Update 2025” product showcase on December 17. As of December 15, 2025, COIN shares are down roughly 4%–5% in U.S. trading, with volatility once again at the center of the story. Finviz Below is a…
Gartner (NYSE: IT) Stock News Today (Dec. 15, 2025): AI Disruption Fears, Insider Buying, Analyst Targets and What Could Move Shares Next

Gartner (NYSE: IT) Stock News Today (Dec. 15, 2025): AI Disruption Fears, Insider Buying, Analyst Targets and What Could Move Shares Next

Gartner, Inc. (NYSE: IT) stock is back in focus on Dec. 15, 2025 as investors weigh a messy mix of forces: a year-long selloff tied to artificial intelligence disruption worries, fresh institutional-position headlines, notable insider activity, and a steady drumbeat of Wall Street price-target updates. As of 15:26 UTC on Monday, Gartner shares traded at $242.94, up about 3.9% from…
Walmart Stock (WMT) News Today: Nasdaq Move, CEO Transition, Holiday Momentum and Fresh Analyst Targets (Dec. 15, 2025)

Walmart Stock (WMT) News Today: Nasdaq Move, CEO Transition, Holiday Momentum and Fresh Analyst Targets (Dec. 15, 2025)

Walmart Inc. stock (WMT) is back in focus on Dec. 15, 2025 as investors weigh a rare combination of near-term retail catalysts and longer-term strategic shifts: a completed move to the Nasdaq, a major CEO transition set for early 2026, and holiday-season momentum following a “beat-and-raise” earnings report last month. As of 15:50 UTC on Monday, Walmart shares were trading…
CNO Financial Group (CNO) Stock Hits a Record High as Jefferies Upgrades to “Buy” — Today’s News, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

CNO Financial Group (CNO) Stock Hits a Record High as Jefferies Upgrades to “Buy” — Today’s News, Analyst Forecasts, and What Investors Are Watching (Dec. 15, 2025)

CNO Financial Group, Inc. (NYSE: CNO) is in the spotlight on Monday, December 15, 2025, after the stock surged to fresh record territory and logged one of its strongest sessions of the year. Shares traded around $43.26, up roughly 4.9% on the day, after touching an intraday high near $43.40. The move comes as Wall Street digests a notable Jefferies…
Costco Stock (COST) Today: Roth Downgrade Ignites Valuation Debate as Analysts Split on 2026 Upside

Costco Stock (COST) Today: Roth Downgrade Ignites Valuation Debate as Analysts Split on 2026 Upside

December 15, 2025 — Costco Wholesale Corporation (NASDAQ: COST) stock traded lower on Monday as Wall Street digested a fresh downgrade that zeroed in on a key investor question heading into 2026: Is Costco’s premium valuation still justified if membership and traffic trends cool, even slightly? StockAnalysis As of the latest available trading data, COST changed hands around the mid-$870s,…
Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health Stock (OSCR) News Today: ACA Subsidy Cliff, Analyst Price Targets, and 2026 Open Enrollment Signals (Dec. 15, 2025)

Oscar Health, Inc. (NYSE: OSCR) is back in the spotlight on December 15, 2025, as investors track a rare triple intersection of (1) U.S. health-policy headlines, (2) new analyst coverage and price-target resets, and (3) the most time-sensitive part of Affordable Care Act (ACA) open enrollment. As of the latest available market data, OSCR last traded around $16.63, with a…
Lumentum (LITE) Stock News and Forecast for Dec. 14, 2025: What’s Driving the Swing, New Filings, and Analyst Targets

Lumentum (LITE) Stock News and Forecast for Dec. 14, 2025: What’s Driving the Swing, New Filings, and Analyst Targets

Published: December 14, 2025 Lumentum Holdings Inc. (NASDAQ: LITE) heads into the new week in the spotlight after a sharp, late-week reversal that reminded investors of two truths about the stock in 2025: the AI data-center optics narrative can power extraordinary rallies, but the same momentum can also snap back fast when markets turn risk-off. On the most recent trading…
Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences (RCUS) Stock News, Forecasts and Analyst Targets — Dec. 14, 2025 Update

Arcus Biosciences, Inc. (NYSE: RCUS) is ending the weekend under a bright—and volatile—spotlight after a major clinical-program reset triggered a sharp Friday selloff. As of Sunday, December 14, 2025, the last reported close was $21.53, down 14.36% from the prior session, reflecting investor repricing after Arcus and partner Gilead halted a pivotal upper-GI cancer study. StockAnalysis What comes next for…
RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

RH Stock News & Forecast (NYSE:RH) on Dec. 14, 2025: Q3 FY2025 Earnings, Guidance Reset, and New Analyst Price Targets

Published: Sunday, December 14, 2025 (U.S. markets last closed Friday, Dec. 12) RH (NYSE:RH)—the luxury home furnishings and lifestyle retailer—heads into the new week with investors digesting a busy stretch of catalysts: a fresh quarterly report, updated full‑year outlook, and a wave of analyst target changes that reshaped the near‑term narrative around tariffs, margin pressure, and a still‑sluggish housing backdrop.…
CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. Stock (NASDAQ: CCC): $500M Buyback, Debt-Funded ASR, Analyst Price Targets, and What’s Next (Dec. 14, 2025)

CCC Intelligent Solutions Holdings Inc. shares are in focus this weekend after the company unveiled a major capital-return move that instantly reshaped the near‑term narrative around the stock: a fresh $500 million share repurchase authorization, anchored by a $300 million accelerated share repurchase (ASR) funded with new term-loan borrowings. SEC Below is a detailed look at what’s new on Dec.…
Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant (IMVT) Stock News and Forecast for Dec. 14, 2025: $550M Financing Closes, Roivant Buys $350M, Analysts Update Targets

Immunovant, Inc. (NASDAQ: IMVT) stock is closing out the week in focus after the company completed a major equity raise designed to bolster funding for its autoimmune pipeline—while its controlling shareholder, Roivant Sciences, stepped in as the largest buyer. As of the most recent market close ahead of Sunday, December 14, 2025, IMVT shares were around $26.42, up about 6.6%…
1 28 29 30 31 32 50

Stock Market Today

  • Forgent Power Solutions Raises $1.5 Billion in Oversubscribed NYSE IPO
    February 5, 2026, 3:19 PM EST. Forgent Power Solutions completed a $1.5 billion initial public offering (IPO) on the New York Stock Exchange, pricing at $27 per share. The oversubscribed offering, led by Goldman Sachs, Jefferies, and Morgan Stanley, saw demand exceeding 15 times the shares available. Forgent, a maker of electrical distribution equipment crucial for AI data center construction, U.S. electric grid upgrades, and manufacturing onshoring, was valued at $8.6 billion. The company's backlog rose nearly 50% to $1.5 billion by year-end, with 40% from new clients like Brookfield Renewable and PG&E. Projected EBITDA growth to $520 million by 2027 justifies the 16x multiple paid. Private equity firm Neos Partners, which built Forgent through acquisitions and invested in manufacturing capacity, reduced its stake to 81.6% post-IPO. Shares traded 3% above offer on debut, reflecting strong market interest amid cautious pricing.
Go toTop